Malaria Clinical Trial
Official title:
Long Term Effects of Insecticide Treated Bednets on the Morbidity and Mortality Caused by Malaria and on the Overall Mortality in Young Children of a Rural Population in Burkina Faso
Insecticide-impregnated bed nets and curtains (ITN) have been shown to be effective against
malaria. However, given that most ITN studies were of limited length, researchers have
postulated the hypothesis that in areas of intense malaria transmission and due to possible
interactions with immunity development, ITN interventions may cause no effect at all or even
a long-term increase in malaria morbidity and mortality.
The overall objective of the trial is to analyse the long-term effects of ITN on child
morbidity and mortality in an area of intense malaria transmission. The specific objective
is to analyse if there is a difference in the rates of malaria morbidity and mortality as
well as in all-cause mortality in children being protected with ITNs from birth compared to
children protected with ITNs from age 6 months onwards.
The study is conducted in the Nouna Health District, in Burkina Faso, and specifically in a
sub-portion of the District under demographic surveillance since 1999. The sub-portion of
the District under demographic surveillance includes a total population of 70 000
individuals, distributed in 42 villages and in the town of Nouna. The region is a dry
Savannah characterised by high levels of malaria transmission.
The study design entails a prospective community-based trial, with newborn children being
identified at the village level and then individually randomised to receive either
intervention A or intervention B. Intervention A is defined as ITN protection from age 0 to
59 months (i.e. protection from birth). Intervention B is defined as ITN protection from age
6 to 59 months (i.e. protection from 6 months onwards). Enrollment in the study cohort in
continued until the sample size is reached (n = 2 600, 1 300 group A and 1 300 group B).
Detailed data on morbidity is collected through means of a prospective follow up on a
sub-sample of 420 children from 6 sentinel villages (210 from group A and 210 from group B).
These 420 children are visited daily by field workers who measure their temperature. In case
of fever, field workers take a blood sample through finger prick to be analysed for malaria
parasitaemia. Treatment free of charge is organised for all children in this subsample. In
addition, these children are visited twice a year for the collection of clinical (malaria
episodes, anaemia) and parasitological (rates of malaria parasitaemia, parasite density)
parameters. Data collection on this subsample of children is meant to last from June 2000 to
December 2003. For study purposes, falciparum malaria is defined as 37.5 C or more plus at
least 5 000 parasites per micro-litre.
All-cause mortality in the overall study sample (2 600 children) are ascertained through
means of a demographic surveillance system (DSS), which regularly monitors deaths (as well
as births and migration) in the region. The causes of death are identified through means of
verbal autopsy. All children enrolled in the study are followed up through means of the DSS
from birth up to 5 years of age.
The primary study outcome will be the five-year all-cause mortality in the total number of
children enrolled in the study (2 600). Secondary outcomes will be the study of
malaria-specific mortality, clinical parameters, and parasitological parameters in a
sub-sample of the study cohort (420).
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
Completed |
NCT02605720 -
Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns
|
Phase 3 |